Gallium-68 Labeled LM3 PET/CT in Neuroendocrine Tumors

NCT04318561 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumors

Interventions

DIAGNOSTIC_TEST: Gallium-68 NODAGA-LM3 PET/CT
DIAGNOSTIC_TEST: Gallium-68 DOTA-LM3 PET/CT
DIAGNOSTIC_TEST: Gallium-68 DOTATATE PET/CT

Sponsor

Peking Union Medical College Hospital